The addition of sirolimus to cyclosporine and steroids inhibits the anti-equine antibody response in renal transplant recipients treated with antithymocyte globulin

American Journal of Transplantation

Volumn 3, Issue 4, 2003, Pages 497-500

  Pescovitz, Mark D ^a   Book, Benita K ^a   Henson, Sharon ^a   Leapman, Stephen B ^a   Milgrom, Martin L ^a   Kimball, Jess ^b   Norman, Douglas ^a   Filo, Ronald S ^a  

^a INDIANA UNIVERSITY   (United States)

^b ORASURE TECHNOLOGIES INC   (United States)

Author keywords

Antibody; Human kidney; Sirolimus

Indexed keywords

ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY;

ADULT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HORSE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; SENSITIZATION;

ADRENAL CORTEX HORMONES; ADULT; ANTIBODIES; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; KIDNEY TRANSPLANTATION; MIDDLE AGED; SIROLIMUS;

EID: 0037990035     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-6143.2003.00065.x     Document Type: Article

References (18)

1. Merion RM. Current use of polyclonal anti-lymphocyte antibody preparations. Transplant Proc 1999; 31: 2208-2218.
2. Szczech LA, Feldman HI. Effect of anti-lymphocyte antibody induction therapy on renal allograft survival. Transplant Proc 1999; 31 (Suppl. 3B): 9-10.
3. Prin Mathieu C, Renoult E, Kennel De March A, Béné MC, Kessler M, Faure GC. Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients. Nephrol Dial Transplant 1997; 12: 2133-2136.
4. Tatum AH, Bollinger RR, Sanfilippo F. Rapid serologic diagnosis of serum sickness from antithymocyte globulin therapy using enzyme immunoassay. Transplantation 1984; 38: 582-586.
5. Niblack G, Johnson K, Williams T, Green W, Ridhie R, MacDonell R. Antibody formation following administration of anti-lymphocyte serum. Transplant Proc 1987; 19: 1896-1898.
6. Shield CF, Fucello AJ, Marlett P, Goldstein G. Human antibody responses to antilymphocytic preparations in renal transplant patients. Transplant Proc 1987; 19: 2217-2218.
7. Madaio MP. Life-threatening thrombocytopenia complicating antithymocyte globulin therapy for acute kidney transplant rejection. Transplantation 1988; 45: 647-650.
8. Bielory L, Gascon P, Lawley TJ, Young NS, Frank MM. Human serum sickness, a prospective analysis of 35 patients treated with equine anti-thymocyte globulin for bone marrow failure. Medicine 1988; 67: 40-44.
9. Filo RS, Book B, Pescovitz MD, Milgrom ML, Leapman SB. Association of sensitization to horse anti-lymphocyte/thymocyte globulin with recipient age and decreased renal allograft survival rates. Transplant Proc 1993; 25: 577-580.
10. Kelly PA, Gruber SA, Behbod F, Kahan BD. Sirolimus a new, potent immunosuppressive agent. Pharmacotherapy 1997; 17: 1148-1156.
11. Sehgal S. Rapamune (Sirolimus, rapamycin): an overview and mechanism of action. Ther Drug Monit 1995; 17: 660-665.
12. Thomson AW, Propper DJ, Woo J, Whiting PH, Milton JI, Macleod AM. Comparative effects of rapamycin, FK 506 and cyclosporine on antibody production, lymphocyte populations and immunoglobulin isotype switching in the rat. Immunopharmacol Immunotoxicol 1993; 15:355-369.
13. Propper DJ, Woo J, Macleod AM, Catto GR, Thomson AW. The effects of rapamycin on humoral immunity in vivo. Suppression of primary responses but not of ongoing alloantibody synthesis or memory responses. Transplantation 1992; 54: 1058-1063.
14. Kahan BD. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study. Lancet 2000; 356: 194-202.
15. Kimball J, Pescovitz MD, Book BK, Norman D. Mycophenolate mofetil reduces human IgG anti-ATGAM antibody formation. Transplantation 1995; 60: 1379-1383.
16. Allison AC, Almquist SJ, Muller CD, Eugui EM. In vitro immunosuppressive effects of mycophenolic acid and an ester pro-drug, RS-61443. Transplant Proc 1991; 23: 10-14.
17. Eugui EM, Mirkovich A, Allison AC. Lymphocyte-selective antiproliferative and immunosuppressive activity of mycophenolic acid and its morpholinoethyl ester (RS-61443) in rodents. Transplant Proc 1991; 23: 15-18.
18. Grailer A, Nichols J, Hullet D, Sollinger HW, Burlingham WJ. Inhibition of human B cell responses in vitro by RS-61443, cyclosporine A and DAB486 IL-2. Transplant Proc 1991; 23: 314-315.